When: Price reaches $243-244 (20 SMA / Bollinger mid-band)

Then: Re-engage another 25%

When: $257: 50 SMA reclaim on volume

Then: Re-engage remaining 25%, full position restored

When: $215-220 on elevated volume (>15M) with RSI <20, bullish divergence, declining volume climax, MACD hooking up

Then: Deploy remaining capital in tranches at capitulation flush with technical confirmation

Trim 25-40% into strength in the 240-250 supply zone, retain 60-75% of position as a dividend-paying core, re-engage at 236-237 on 10 EMA reclaim with volume or at 215-220 on a capitulation flush; do not extend trim to 50%

• Opposes escalating trim to 50% on 229.20 break, calling it a directional bet disguised as risk management
• Cites 30% drawdown already absorbed with RSI at 26.94 for five sessions as textbook selling exhaustion
• Highlights 9/23 capitulation candle (16.6M shares, 4.82% gap down) followed by no follow-through as successful test of supply, not new down leg
• Argues 16.87x forward earnings with 3.33% yield and 46.5% operating margin is not expensive in absolute terms for a defensive consumer franchise
• Contests characterization of Q2 EPS of 3.32 as 'financial engineering' due to 0.9% share count reduction, calling buybacks a legitimate return of capital
• Asserts 0.45 beta makes MCD preferable to high-multiple growth names in a higher-for-longer rate environment
• Notes FCF of 1.98B covered dividend of 1.32B in Q2 2026 with 2.6x net debt to EBITDA and 14.93B TTM EBITDA
• States dividend payout ratio of 81% of FCF is not a risk given consistent coverage and decades of annual raises
• Supports re-engagement triggers at 236-237 (10 EMA reclaim with volume) or 215-220 (capitulation flush)

→ vs aggressive: The 50% trim call on a 229.20 break and another 15-20% on a lower high below 246 is not risk management but market forecasting, which has a terrible track record at valuation inflection points

→ vs aggressive: The valuation argument ignores that MCD at 16.87x forward with 3.33% yield and these margins is not expensive relative to any defensive consumer name, and the market is already pricing in the bear case at 233 versus 280

→ vs aggressive: The buyback argument is weak: a 0.9% share count reduction is legitimate return of capital that compounds, not a fake number, and the same reduction makes the dividend sustainable

→ vs aggressive: High rates are a reason to prefer MCD, not sell it—0.45 beta means it should outperform high-multiple growth names risk-adjusted in a higher rate regime

→ vs aggressive: The 81% FCF payout is not a dividend risk given consistent coverage, 2.6x leverage, and decades of annual raises—calling it at risk is fearmongering, not analysis

→ vs aggressive: The 9/23 capitulation candle is ambiguous and could represent the close of an old down leg rather than the start of a new one—being unable to entertain a tradable low is one-sided, not rigorous

Trim 30-40% into strength at 240-250, retain 65-70% core, contingent trim if 236 not reclaimed within 10 sessions, re-engage only on 236-237 EMA reclaim with volume confirmation and MACD turn

• Trim magnitude should be 30-40% into the planned 240-250 strength zone
• Add time-based contingency: if 236 not reclaimed on daily close within 10 trading sessions, execute 25% of trim at market regardless
• Re-engagement trigger should be 10 EMA reclaim on volume at 236-237 with confirming MACD histogram turn; eliminate or tighten the 215-220 capitulation flush trigger
• If 257 ceiling is taken out before trim executes, abort trim and return to full position, set new ceiling at 50 SMA, reassess after Q3 print
• Position sizing should be anchored at 65-70% retained core (tighter band than trader's 60-75%)
• Sentiment reading of 5.0/10 signals silence, not stability; Q3 print will be the first catalyst forcing real re-pricing
• Forward P/E of 16.87x is not egregious overpay; stable cash-flow franchises like MCD strengthen相对ly in higher-for-longer rate environment
• EPS growth of ~6% year-over-year is partly explained by 0.9% share count reduction, not organic strength; earnings quality should not be leaned on as standalone bull case

→ vs aggressive: Escalation plan (50% trim with cascading thresholds at 229.20 and lower highs below 246) is forecasting a path, not risk management; underpricing gap risk of being wrong on trim threshold if stock gaps up through 246 on CPI print

→ vs aggressive: Ignoring forward multiple entirely; at 16.87x forward earnings with MCD's growth profile, it's not a screaming buy but not egregious overpay either

→ vs aggressive: Using Polymarket/rates data inconsistently: higher-for-longer rates compress cyclical multiples but argue FOR stable cash-flow franchises relative to high-multiple peers

→ vs conservative: Narrative optimism leaking through; 'maybe' capitulation on 9/23 candle cannot form the basis of a plan while trend stack screams broken—price below 10 EMA, 50 SMA, and 200 SMA all sloping down is base breaking, not base forming

→ vs conservative: Waiting indefinitely for a 'snapback that always comes' after 30% drawdown is not risk management; 30% drawdowns can become 40%, and re-engagement target of 215-220 implies substantial additional downside

→ vs conservative: Overcorrecting on buyback argument; 0.9% share count reduction is legitimate but organic revenue only up 3.8%, so headline EPS growth quality is what it is and cannot anchor a bull case in isolation

→ vs conservative: Both sides are partially right on buyback and neither is conceding the other's point

→ vs neutral: Position sizing band of 60-75% is too wide; should be anchored tighter at 65-70% to balance downside protection with meaningful dividend-paying core and optionality to add on confirmed reversal